Highly different risk estimates for atypical femoral fracture with use of bisphosphonates - debate must be allowed!
- PMID: 22900912
- PMCID: PMC3427619
- DOI: 10.3109/17453674.2012.718517
Highly different risk estimates for atypical femoral fracture with use of bisphosphonates - debate must be allowed!
Figures

Similar articles
-
Retrospective review of patients with atypical bisphosphonate related proximal femoral fractures.Injury. 2017 Jun;48(6):1159-1164. doi: 10.1016/j.injury.2017.03.025. Epub 2017 Apr 4. Injury. 2017. PMID: 28410753
-
Bisphosphonate-associated atypical femur fracture in a 90-year-old Caucasian woman.Hong Kong Med J. 2015 Jun;21(3):286.e2-3. doi: 10.12809/hkmj144384. Hong Kong Med J. 2015. PMID: 26045077 No abstract available.
-
Can long-term bisphosphonate use causes low-energy fractures? A case report.Osteoporos Int. 2014 Feb;25(2):773-6. doi: 10.1007/s00198-013-2428-0. Epub 2013 Jul 4. Osteoporos Int. 2014. PMID: 23824297
-
Teriparatide treatment in an adult patient with hypophosphatasia exposed to bisphosphonate and revealed by bilateral atypical fractures.Joint Bone Spine. 2018 May;85(3):365-367. doi: 10.1016/j.jbspin.2017.12.001. Epub 2017 Dec 12. Joint Bone Spine. 2018. PMID: 29246529 Review.
-
Questioning the association between bisphosphonates and atypical femoral fractures.Ann N Y Acad Sci. 2015 Jan;1335(1):1-9. doi: 10.1111/nyas.12551. Epub 2014 Oct 7. Ann N Y Acad Sci. 2015. PMID: 25294742 Free PMC article. Review.
Cited by
-
Osteoporosis: the emperor has no clothes.J Intern Med. 2015 Jun;277(6):662-73. doi: 10.1111/joim.12366. J Intern Med. 2015. PMID: 25809279 Free PMC article. Review.
-
Surveillance of atypical femoral fractures in a nationwide fracture register.Acta Orthop. 2022 Jan 11;93:229-233. doi: 10.2340/17453674.2022.1380. Acta Orthop. 2022. PMID: 35019144 Free PMC article.
-
Dichotomous location of 160 atypical femoral fractures.Acta Orthop. 2013 Dec;84(6):561-4. doi: 10.3109/17453674.2013.866193. Epub 2013 Nov 29. Acta Orthop. 2013. PMID: 24286566 Free PMC article.
-
Risk of atypical femoral fracture during and after bisphosphonate use.Acta Orthop. 2015 Feb;86(1):100-7. doi: 10.3109/17453674.2015.1004149. Epub 2015 Jan 13. Acta Orthop. 2015. PMID: 25582459 Free PMC article.
References
-
- Feldstein A, Black D, Perrin N, Rosales AG, Friess D, Boardman D, Dell R, Santora A, Chandler JM, Rix MM, Orwoll E. Incidence and demography of femur fractures with and without atypical features. J Bone Miner Res. 2012;27(5):977–986. - PubMed
-
- Shane E, Burr D, Ebeling PR, Abrahamsen B, Adler RA, Brown TD, Cheung AM, Cosman F, Curtis JR, Dell R, Dempster D, Einhorn TA, Genant HK, Geusens P, Klaushofer K, Koval K, Lane JM, McKiernan F, McKinney R, Ng A, Nieves J, O’Keefe R, Papapoulos S, Sen HT, van der Meulen MC, Weinstein RS, Whyte M. Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2010;25(11):2267–94. - PubMed
-
- Schilcher J, Michaelsson K, Aspenberg P. Bisphosphonate use and atypical fractures of the femoral shaft. N Engl J Med. 2011;364(18):1728–37. - PubMed
-
- Alberg AJ, Ford JG, Samet JM. Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition) Chest. 2007;132(3 Suppl):29S–55S. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical